Uterine leiomyomas are benign uterine tumors characterized by extracellular matrix remodeling, increased collagen deposition, and increased smooth muscle cell (SMC) proliferation. The reactive oxygen species (ROS) producing NADPH oxidase complex has been shown to be involved in the signaling pathways of several growth factors, cytokines, and vasoactive agents that stimulate proliferation of a variety of cell types. Our objective was to test the hypothesis that ROS derived from NADPH oxidase is a necessary component of the MAP kinase mitogenic pathway activated by platelet derived growth factor (PDGF) and epidermal growth factor (EGF) in leiomyoma SMCs (LSMCs). Primary cell cultures of LSMCs were used as our experimental model. Our results showed that stimulation of these cells with PDGF or EGF caused a marked increase in intracellular ROS production and that the NADPH oxidase inhibitor, DPI, blocks ROS production. In addition, inhibition of ROS production by NADPH oxidase inhibitors blocked, in a dose-dependent manner, the EGF-and PDGF-induced increase in [
INTRODUCTION
Uterine leiomyomas, or fibroids, are characterized by an increase in SMC proliferation and excessive deposition of extracellular matrix proteins, primarily collagens type I and III [1] [2] [3] . Recent survey studies have reported that over 600 000 hysterectomies are performed in the United States and that uterine leiomyomas represent 29.4% and 41.4% of the hysterectomies in women ages 18-44 and 45-64, respectively [4] . Epidemiological studies have shown that 7 out of every 10 Caucasian women and 8 out of every 10 African American women will eventually develop uterine leiomyomas [5] .
Ovarian steroid hormones are known to play a central role in the regulation of uterine leiomyoma growth because leiomyomas develop only in postpubertal and premenopausal women. A significant reduction in tumor size is observed after the onset of menopause and in response to treatment with gonadotropinreleasing hormone or progesterone antagonists [6, 7] . Steroid hormones induce mitogenic effects directly through their receptors or by regulating expression of growth factors such as EGF and PDGF and their respective receptors [7, 8] . Both EGF and PDGF receptors have previously been identified in LSMCs [9, 10] . Furthermore, EGF and PDGF have been shown by numerous investigators to stimulate the proliferation of LSMCs [9, 11] . Vascular SMCs show similar mitogenic responses to these same growth factors [12, 13] .
The pathophysiology of uterine leiomyomas is similar to that of other fibrotic conditions such as atherosclerosis, vascular restenosis, and liver, pancreatic, and renal interstitial fibrosis, in which an injury triggers normally quiescent cells to dedifferentiate into a myofibroblast-like, more proliferative phenotype [14] [15] [16] [17] . It is likely that the development of leiomyomas may parallel these pathological conditions, occurring in response to some type of injury to the myometrium such as hypoxia.
Reactive oxygen species (ROS), which were once regarded as purely cytotoxic, are now recognized as effective secondmessenger molecules regulating protein modifications, gene expression, cell proliferation, migration, and differentiation as well as tissue remodeling in a variety of cell types [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . ROS activation is biphasic [28] , and the signaling effects can be both immediate and long lasting. NADPH oxidase has been shown to serve as the primary source of intracellular ROS, specifically hydrogen peroxide, in a variety of cell types [29, 30] . Sundaresan and colleagues [31] were the first to uncover the importance of increasing intracellular ROS levels in response to specific growth factor ligands. This group showed that on treatment with PDGF, ROS levels in vascular SMCs rose rapidly and returned to baseline within approximately 30 min. Furthermore, after blocking the PDGF-stimulated generation of intracellular ROS, they noted a marked inhibition of MAPK activation and proliferation. More recent studies have shown that growth factors (including EGF and PDGF), chemokines, cytokines, and vasoactive agents such as angiotensin can induce NADPH oxidase-dependent ROS production, which in turn has been shown to activate various MAPKs that regulate downstream cell proliferation or matrix production [19, 22, 25] .
The focus of our research is to gain a better understanding of the signaling pathways involved in regulation of uterine leiomyoma growth. Our goals in this study were to determine 1) whether ROS are necessary components of the signaling pathways for PDGF and EGF in LSMCs and 2) the potential involvement of MAPK1/MAPK3 as intermediate molecules mediating the effects of ROS on leiomyoma SMC proliferation. Our results show that NADPH oxidase-derived ROS are indeed an important component of thesesignaling pathways.
MATERIALS AND METHODS

Chemicals and Reagents
PDGF (120-HD) and EGF (236-EG) were purchased from R&D Systems. Diphenyleneiodonium chloride (DPI; D2926) and DMSO (D2650) were purchased from Sigma. Tritiated thymidine ([ 3 H]thymidine) (NET-027) was purchased from PerkinElmer. Thirty percent hydrogen peroxide (H325-100) and bovine serum albumin (BP1600-100) were purchased from Fisher Scientific. Restore Western Blot Stripping Buffer (21059), BCA protein assay kit, and SuperSignal West Pico Chemiluminescent Substrate (34080) were purchased from Thermo Scientific. Anti-MAPK1/MAPK3 and antiphosphorylated MAPK1/MAPK3 antibodies and anti-mouse and anti-rabbit HRP-linked antibodies were purchased from Cell Signaling. Dulbecco modified Eagle medium (DMEM; 12-614F), penicillin-streptomycin (17-602E), phenol-redfree DMEM (PRF-DMEM, 12-917F), and L-glutamine (17-605E) were purchased from Biowhittaker. Dubelco PBS/Modified (SH30264.01), fetal bovine serum (FBS; SH30071.03) and bovine calf serum (BCS; SH30072.03) were purchased from Hyclone. Carboxy-H 2 DCFDA (5-[and-6]-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate) (C400), dihydroethidium stabilized in DMSO (D23107), and Trizol Reagent (15-596-018) were purchased from Invitrogen.
Cell Culture
Leiomyomas were obtained from patients undergoing hysterectomy who had given written consent in accordance with the University of Illinois and Northwestern University institutional review board committees. Tissues were minced, digested in collagenase overnight, and then placed into flasks in DMEM þ 5% FBS þ 5% BCS, which will be referred to as DMEM/10% serum. Cells were characterized for expression of the smooth muscle cell specific markers a-actin and desmin, and for lack of expression of the fibroblast-specific marker vimentin. These primary cells were then cultured in DMEM/10% serum, supplemented with BCS, penicillin-streptomycin (10 000 U pen/ml, 10 000 lg strep/ml), and L-glutamine (200 mM) in 75 cm 2 cell culture flasks (Midwest Scientific, 90075). Cells were maintained at 378C in a humidified atmosphere of 95% air and 5% CO 2 . Cells were used in experiments between passages 4 and 8.
Measurement of Intracellular ROS Production: Dihydroethidium
LSMCs were cultured on two-well collagen-coated glass slides (Becton Dickinson, 354627) in 2 ml per well of DMEM/10% serum at a density of 50 000 cells per well. Cells were tested once they attained approximately 50% confluence to prevent fluorescent dye from becoming trapped in the extracellular matrix. The generation of intracellular ROS was measured using dihydroethidium bromide (DHE) as a fluorescent probe.
To determine the effects of PDGF or EGF on intracellular ROS production, cells received the following treatments for increasing time increments of 0, 5, 10, or 15 min: DMEM þ 0.1% BSA, 10 ng/ml PDGF (maximal dose), or 100 ng/ml EGF (maximal dose). All treatments were applied using PRF-DMEM containing 0.1% BSA, pen-strep, and L-glutamine. Cells were washed once using PRF-DMEM/0.1% BSA. Cells were then loaded with the fluorescent DHE dye (10 lM) in PRF-DMEM/0.1% BSA for 20 min. This dye can passively enter cells and produces a red fluorescent signal on its oxidation by intracellular ROS. The oxidized ethidium bromide then becomes intercalated within the cell's DNA, producing a long-lasting fluorescence. After removal of the dye, cells were washed twice with PRF-DMEM. The medium was then removed and cells were visualized using a Zeiss Axiovert 25 fluorescence microscope. Pictures were taken using a Zeiss Axiocam camera to record fluorescent images. An increase in intracellular fluorescence indicated an increase in intracellular ROS production.
Measurement of Intracellular ROS Production: Carboxy-H 2 DCFDA LSMCs were cultured in 35-mm l-dishes (Ibidi) in 800 ll of DMEM/10% serum at a density of 2000 cells per dish. Once cells attained 50% confluence the experiment was performed. Cells were washed three times in warm DPBS, and carboxy-H 2 DCFDA dye was added to the cells in 800 ll of DPBS at a 10 lM concentration. After 15 min of incubation, dye was removed, cells were washed two times, and treatment was added. Cells were exposed to either DPBS alone (negative control), H 2 O 2 (10 lM) (positive control), EGF (50 ng/ ml) or PDGF (10 ng/ml) in DPBS for 15 min. Growth factors were added in absence or presence of 25 lM DPI. After treatment, cells were washed two times, and images were immediately captured using a fluorescence microscope (Zeiss Axiovert 200M).
Densitometric Quantification of Fluorescence Images
Individual cells were randomly selected from several different microscopic fields, and fluorescence as well as DIC-Nomarski images were captured and saved as TIFF files. Images were loaded and analyzed on Axiovision software (Zeiss). The intracellular compartment of cells was determined by using DIC images. To be consistent with regards to the areas of fluorescence, measurements circles were drawn around the nucleus of every cell. The average of the fluorescence measurements from each cell was taken and used for statistical analysis. To examine stimulation of cell proliferation by exogenous ROS, cells were placed in fresh DMEM/0.5% FBS and were pulse-treated once each hour for 5 h with hydrogen peroxide (10, 50, 100, or 200 lM). LSMCs were cultured as described in the previous section. To determine whether proliferation observed in response to EGF or PDGF could be inhibited by treatment with a ROS inhibitor, cells were maintained in DMEM/0.5% FBS and pretreated with 200 lL of diphenyleneiodonium chloride (DPI) at increasing concentrations of 0, 5, 25, or 50 lM for 60 min. DPI was then removed and cells were washed twice with DMEM/0.5% FBS and then treated with either 50 ng/ml EGF or 10 ng/ml PDGF for 24 h. Control cells that were not pretreated with the inhibitor were treated with either EGF (50 ng/ml), PDGF (10 ng/ml), or no growth factor. Cells were labeled during the final 6 h of treatment with [ 
Assessment of Proliferation Using Cell Counts
LSMCs were plated in six-well plates in 2 ml of DMEM/10% serum at a density of 50 000 cells per well. On attaining 80% confluence, cells were growth arrested in DMEM/0.5% FBS for 24 h, and experiments were performed. To determine the effects of H 2 O 2 on cell numbers, cells were given new medium every hour for 8 h per day over a 2-day period. Treatments consisted of DMEM/0.5% FBS or H 2 O 2 (20 lM and 100 lM). To determine the effects of DPI on cell numbers of EGF-and PDGF-stimulated cells, cells were exposed to either DMEM/0.5% FBS, EGF (50 ng/ml), or PDGF (10 ng/ ml) for 48 h. Growth factors were added in the absence or presence of DPI (25 lM) . At the end of the treatment period, cells were detached with 1 ml of trypsin for 8 min, mixed with 1 ml of DMEM/10% serum, and counted using a hemocytometer.
COL1A2 and COL3A1 Gene Expression
LSMCs were grown in 60-mm culture dishes and allowed to attain 80% confluence. Cells were then washed and switched to DMEM/0.5% FBS. Cells 342 then were given hourly pulses of hydrogen peroxide (20 lM) for 5 h or were treated with one 200-lM hydrogen peroxide pulse for 24 h. Total RNA was isolated from cells using Trizol Reagent. Complementary DNA synthesis was performed and followed by qRT-PCR to determine relative fold differences in collagen type 1 alpha 2 (COL1A2) and collagen type 3 alpha 1 (COL3A1) mRNA expression in response to ROS (Applied Biosystems TaqMan Gene Expression Assay for COL3A1: Hs00164103_m1; Applied Biosystems TaqMan Gene Expression Assay for COL1A2: Hs00164099_m1).
Immunoblotting
LSMCs were serum starved for 1 h in 60-mm dishes. Two hundred microliters of concentrated hydrogen peroxide (10 lM final concentration), EGF (50 ng/ml final concentration), or PDGF (10 ng/ml final concentration) were added directly to the cells, and treatments continued for the specified time periods. When pretreatment with NADPH oxidase inhibitor was necessary, cells were exposed to DPI for 60 min, and concentrated growth factors were then added to the cells in the presence of the inhibitor. Cell lysates were harvested by removing medium and adding warm (958C) 1X-Laemmli sample buffer (LSB) (2% SDS, 10% glycerol, 62.5 mM Tris, pH 6.8). Cells were scraped off the dishes, added to a 1.5-ml tube, sonicated (10 pulses), and stored at À208C. BCA assays were performed on the cell lysates to determine protein concentrations. Either 5 lg (MAPK1/MAPK3 blots) or 45 lg (EGF-R or PDGF-R blots) of total protein were loaded on SDS-PAGE gels (12%) and run initially at 80 V for 30 min, then at 150 V for 90 min. Protein transfer was carried out at 60 mA for 16 h at room temperature. Primary antibody (antiphosphorylated MAPK1/MAPK3 1:2000 in 5% milk, anti-MAPK1/ MAPK3 1:1000 in 3% BSA, antiphoshporylated EGF-R and anti-PDGF-R 1:500 in 5% milk, anti-EGF-R and anti-PDGF-R 1:500 in 3% BSA) incubation was performed for 90 min at room temperature. HRP-conjugated secondary antibody was incubated with membranes in 5% milk for 60 min at room temperature (1:10 000). The SuperSignal West Pico Chemiluminescent Substrate kit was used as substrate for HRP. Membranes were first probed with antiphosphorylated MAPK1/MAPK3 antibody and then reprobed with anti-total MAPK1/MAPK3 as a loading control. Membranes were stripped with Restore Western Blot Stripping buffer from Thermo Scientific before being reprobed.
Densitometric Analysis of Western Blots
Films developed after exposure to chemiluminescence on the membranes were scanned and images saved at high resolution in a TIFF format. Images were analyzed using the ImageJ software from the National Institutes of Health (available at http://rsbweb.nih.gov/ij/download.html). Software was calibrated for optical density measurements using a Kodak no. 3 calibrated step tablet available at http://rsb.info.nih.gov/ij/docs/examples/calibration. Bands of interest were measured by drawing the smallest rectangle capable of measuring the optical density of all the bands. The same rectangle was used to measure all the bands in one film. Measurements of bands referring to the activated form of the proteins (phosphorylated form) were normalized for loading differences using measurements obtained from the bands referring to total protein (loading control). Graphs represent LSmeans and SEM.
FIG. 1. Intracellular ROS production by
LSMCs increases in response to treatment with EGF or PDGF. A) Left panel: Intracellular ROS production is indicated by the presence of red fluorescence in LSMCs in response to PDGF (10 ng/ml) treatment for 15 min; right panel: Bright-field image indicating that the fluorescence is located specifically within the LSMCs. B) LSMCs were exposed to DMEM/0.1% BSA (negative control), EGF (100 ng/ml), or PDGF (10 ng/ml) for increasing time periods up to 15 min. An increase in fluorescence indicated an increase in intracellular ROS production (n ¼ 3; representative image of LSMC response).
Statistical Analysis
Quantitative RT-PCR experiments were performed using the relative standard curve method. To show changes in gene expression relative to control level (control set as 1), each biological replicate was normalized to the average of the control group within each experiment. Relative fold difference values from qRT-PCR experiments and cpm values from [ 3 H]thymidine incorporation experiments in each experiment were checked for normality and common variances, respecting the assumptions for performing analysis of variance. All distributions were normal. Statistical analysis for all experiments followed the same approach. A completely randomized design corresponding to the following linear model was used: Xik ¼ l þ si þ eik, where Xik ¼ an observation, l ¼ population mean, si ¼ effect of ith treatment, and eik ¼ error term. The linear model for densitometry analysis of the Western blots used values for total MAPK1/MAPK3, EGF-R, or PDGF-R as a covariate. A priori comparisons determined by contrasts were used to minimize testing the null hypothesis multiple times (a ¼ 0.05). The contrasts were only performed when analysis of variance indicated significant effect due to treatment. The data analyses for this article were generated using SAS software (SAS Institute Inc.).
RESULTS
EGF and PDGF Stimulate Intracellular ROS Generation
To test our hypothesis that ROS are necessary mediators of EGF and PDGF signaling pathways, we first examined whether EGF or PDGF would induce an increase in intracellular ROS production in LSMCs. Figure 1A indicates an increase in fluorescence after 15 min of stimulation with PDGF, and the bright-field image shows that fluorescence was specifically observed intracellularly. Cells were loaded with DHE fluorescent dye following growth factor treatment, and the presence of fluorescence indicated oxidation of DHE and, therefore, the presence of ROS. Intracellular fluorescence was observed in cells following treatment with either 10 ng/ml PDGF or 100 ng/ml EGF, and fluorescence increased over time, with maximum fluorescence occurring after 15 min of treatment (Fig. 1B) . However, the effects of EGF or PDGF treatment on ROS production were evident as early as 5 min.
NADPH Oxidase Inhibitor Blocks EGF-and PDGFStimulated ROS Production
To capture higher power images and get better intracellular resolution with our intracellular ROS detection experiments, we used another oxidation sensitive dye, carboxy-H 2 DCFDA. We first tested whether this dye was sensitive to oxidation by H 2 O 2 . Indeed, on addition of H 2 O 2 (10 lM) to the culture medium, the compound entered the cells readily and induced a significant increase in intracellular fluorescence ( Fig. 2A) . In the same experiment, we also confirmed the increase in ROS production after LSMC treatment with EGF and PDGF. Similar results were obtained when using DHE dye ( Figs. 2A and 1A , respectively). After validating the carboxy-H 2 DCFDA dye, our next goal was to validate the compound diphenyleneiodonium (DPI) as an inhibitor of the enzymatic complex, which we hypothesize is responsible for ROS production (NADPH oxidase). When cells were treated with EGF or PDGF in the presence of DPI (25 lM) for 15 min, there was a significant drop in the amount of fluorescence observed intracellularly. DIC-Nomarzki images indicate the localization of the cells and, when merged with the fluorescence channel, support the intracellular ROS localization. These results show that carboxy-H 2 DCFDA is a highly sensitive probe that can detect changes in intracellular ROS concentrations, that DPI can block growth factor-induced ROS production by LSMCs, and that the NADPH oxidase complex is active and potentially Figure 2B shows the densitometric analysis of the fluorescence images as a means of quantitatively comparing the different treatments.
NADPH Oxidase Inhibitor Blocks EGF-and PDGFStimulated Proliferation of LSMCs
Based on our results showing that ROS are produced in response to EGF and PDGF, the next logical step was to test the hypothesis that ROS are a necessary component of the EGF and PDGF mitogenic pathways and that NADPH oxidase is the enzymatic complex involved in this receptor-mediated ROS production. After validating DPI, we used this NADPH oxidase inhibitor to block ROS generation in the presence of either EGF or PDGF. We then assessed the effect of DPI on EGF-and PDGF-induced LSMC proliferation by measuring changes in DNA synthesis using [ 3 H]thymidine incorporation assays. Pretreatment of cells with increasing concentrations of DPI before adding EGF resulted in significant inhibition of proliferation when compared to those cells treated with EGF alone (Fig. 3A) . In fact, the levels of DNA synthesis at the two higher concentrations were reduced to levels below those observed in the controls (0.5% FBS only). Similarly, when cells were exposed to DPI prior to treatment with PDGF, a reduction in growth factor-stimulated proliferation was again observed (Fig. 3B) .
The effects of DPI on EGF-or PDGF-stimulated cell proliferation were significant. This inhibitory effect was dose dependent, as the highest concentration of DPI blocked DNA synthesis almost completely.
To confirm whether the results obtained with the [ 3 H]thymidine incorporation assays were paralleled by similar changes in cell number, we performed cell count experiments using a hemocytometer. Cells exposed to either EGF or PDGF in the presence of DPI had a dramatic decrease in cell number in comparison to growth factors alone (Fig. 3C) .
Exogenous H 2 O 2 Stimulates LSMC Proliferation
After demonstrating that inhibition of the ROS-producing NADPH oxidase complex inhibited growth factor-induced cell proliferation, we tested whether an exogenous source of ROS was sufficient to induce LSMC proliferation. ROS are extremely labile and, therefore, difficult to use as a treatment for cells in vitro. In light of this characteristic of hydrogen peroxide, we used increasing concentrations of exogenous hydrogen peroxide (10-200 lM) as pulse treatments once per hour for 5 h and then assessed change in DNA synthesis. Interestingly, hydrogen peroxide at 10 lM increased DNA synthesis, whereas higher concentrations of the compound (50 and 100 lM) had no effect compared to control, and 200 lM was inhibitory (Fig. 4A) . These data indicate that within the range of concentrations used, it was possible to separate the specific mitogenic effects of hydrogen peroxide from its inhibitory effects, which may be related to oxidative stress.
Cell count experiments confirmed that at relatively low concentrations (20 lM) H 2 O 2 causes in increase in cell number compared to untreated control, whereas at higher concentrations (100 lM) it inhibited cell proliferation (Fig. 4B) . 
REACTIVE OXYGEN SPECIES INCREASE PROLIFERATION
NADPH Oxidase Inhibitor Blocks PDGF-Stimulated MAPK1/MAPK3 Activation
To elucidate the inhibitory pathway further, we investigated the involvement of the well-known mitogen-activated protein kinase pathway on ROS-dependent proliferative responses of LSMCs, specifically MAPK1/MAPK3. Both EGF and PDGF induced phosphorylation of MAPK1/MAPK3 within 5 min of treatment with maximum phosphorylation occurring between 10 and 15 min (Fig. 5) . We hypothesized that activation of MAPK1/MAPK3 occurs downstream of the increase in ROS production and that inhibition of ROS production would reduce the level of MAPK1/MAPK3 phosphorylation in response to EGF or PDGF treatment. No effects of DPI treatment on EGFinduced MAPK1/MAPK3 activation were observed (Fig. 6, A  and B) . However, pretreatment of LSMCs with DPI reduced PDGF-induced MAPK1/MAPK3 activation. This result is indicated by the decrease in intensity of the phosphorylated MAPK1/MAPK3 band from the cells treated with 50 lM of DPI in comparison to that observed for growth factor treatment alone (Fig. 6, C and D) . Our results showing that inhibition of PDGF-induced MAPK1/MAPK3 activation by DPI and lack of inhibition of EGF-induced MAPK1/MAPK3 activation suggest a specific regulation of PDGF signaling pathway by ROS.
To test whether DPI was potentially having toxic effects, we decided to focus on the activation of molecules that are not 
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regulated by ROS and would not be affected by DPI unless the inhibitor is having unspecific effects. We measured the ability of EGF-R or PDGF-R to undergo autophosphorylation on exposure to EGF or PDGF in the presence of DPI in LSMCs. Figure 7 provides evidence that LSMCs were able to respond to both growth factors even in the presence of the highest DPI concentration. This result is supported by the lack of a statistically significant reduction of EGF-R and PDGF-R autophosphorylation (Fig. 7, B and D) .
Exogenous H 2 O 2 Stimulates MAPK1/MAPK3 in LSMCs
We next tested whether treatment with exogenous hydrogen peroxide was sufficient to induce MAPK1/MAPK3 phosphorylation. Similarly to the response observed in our [ 3 H]thymidine incorporation experiments, exogenous hydrogen peroxide alone induced activation of the MAPK1/MAPK3 pathway (Fig.  8) . MAPK1/MAPK3 reached maximum activation within 10 and 15 min after hydrogen peroxide treatment returning to basal levels after 30 min.
Effects of Exogenous H 2 O 2 on COL1A2 and COL3A1 Gene Expression in LSMCs
Because our results showed that H 2 O 2 had a positive effect on LSMC proliferation and MAPK1/MAPK3 activation, we tested whether H 2 O 2 might also be involved in regulating collagen expression. Cells were either untreated, given five hourly pulses of 10 lM H 2 O 2, or a higher concentration of H 2 O 2 (100 lM) for 24 h. Total RNA was harvested and analyzed for changes in mRNA levels of COL1A2 and COL3A1 using qRT-PCR. Exogenous H 2 O 2 did not alter COL1A2 and COL3A1 mRNA expression in LSMCs (data not shown). Treatment with either EGF or PDGF also did not affect levels of collagen mRNAs (data not shown).
DISCUSSION
The goal of our study was to determine whether ROS are necessary components of the PDGF and EGF signaling pathways for LSMC proliferation. Our results are the first to demonstrate that ROS generated by the NADPH oxidase system in LSMCs are involved as intermediates in the signaling pathway of these growth factors. The main findings of this study are that 1) LSMCs produce ROS in response to EGF and PDGF, 2) ROS are necessary and sufficient to induce LSMC proliferation, and 3) ROS are necessary and sufficient to induce a fraction of MAPK1/MAPK3 activation in LSMCs.
To determine the role of reactive oxygen species in the mitogenic signaling pathways of EGF and PDGF in LSMCs, we first needed to show that these growth factors induced ROS generation in such cells. EGF and PDGF have been shown previously to stimulate intracellular ROS production in other cells types [22, 24, 31, 32] . Our study is the first to show that both PDGF and EGF induce intracellular ROS generation in LSMCs. This receptor-mediated ROS production was initially discovered in cells of the immune system and shown to be derived from the plasma membrane flavohemoprotein complex NADPH oxidase [33] . One of the first reports of Matsubara and Ziff [34] focusing on nonimmune cells from showed that endothelial cells released superoxide in response to specific cytokines. Since this first evidence linking ROS generation to regulation of inflammatory responses, many other groups have become interested in the role of the NADPH oxidase complex in hyperproliferative disorders [35] . More recently, NADPH oxidase-derived ROS have been implicated as a necessary component of numerous signaling pathways and associated with specialized cell functions [32, [34] [35] [36] [37] .
If ROS are a necessary component of the PDGF and EGF signaling pathways, then the addition of exogenous ROS should mimic the effects of these growth factors. In fact, when treated with exogenous hydrogen peroxide, LSMCs exhibited a notable increase in DNA synthesis and cell number. The pathway by which exogenous ROS produced this effect in LSMCs is still unknown and may not be the same as that of EGF or PDGF. One of the first evidences of the participation of ROS, specifically hydrogen peroxide, in signaling pathways was provided by experiments showing hydrogen peroxidedependent glucose oxidation in response to insulin [38] . ROS were later shown to be required for cell growth and transformation [21, 35, 36] . Hydrogen peroxide has been recognized as a signaling molecule since investigators determined that its concentration can rapidly and transiently increase in response to receptor-mediated signaling events. Furthermore, hydrogen peroxide undergoes quick enzymatic degradation, is diffusible, and can act in a specific and reversible fashion [39, 40] . Rao [42, 43] . Experiments focusing on the role of ROS in normal cell function are complicated by the fact that ROS are extremely short-lived molecules. In our study a low hydrogen peroxide concentration of 10 lM was added as a pulse, every hour for 5 h, in contrast to 200 lM every 3 h for 24 h by Rao and Berk [41] . Our replenishment system allowed us to overcome the problem with hydrogen peroxide being labile and degrading rapidly over time as well as to the use of concentrations that may more closely resemble physiological levels. Although it is difficult to determine what the physiological levels are and how specific hydrogen peroxide action is, we used concentrations that are 20 times lower than several other studies. Furthermore, COL1A2 and COL3A1gene expression was not affected by the same hydrogen peroxide administration regimen, suggesting that the higher proliferation rate was not due to increased collagen deposition or to a general nonspecific effect of hydrogen peroxide. We also observed that the use of concentrations above 50 lM abolished even basal levels of proliferation, confirming the negative effect of high levels of ROS on cells.
Pretreatment with the NADPH oxidase inhibitor DPI significantly inhibited EGF-and PDGF-induced proliferation of LSMCs. These data support our hypothesis that ROS are critical intermediates in the mitogenic signaling pathways of EGF and PDGF and also suggests for the first time the presence of the NADPH oxidase complex in the uterus. DPI has been used successfully by numerous other laboratories to prevent hormone/growth factor-induced, ROS-dependent cell proliferation in vascular smooth muscle cells [44] [45] [46] . DPI pretreatment did not appear to have caused cytotoxic effects at the concentrations used, as cells were able to respond to growth factor treatment with receptor autophosphorylation. This finding suggests a tight regulation of ROS production in the cell. When ROS levels are too high, it is believed that ROS function as potent oxidizing agents, potentially causing oxidative damage and cytotoxic effects. However, if intracellular ROS concentrations fall below a critical level, crucial cellular signaling events might be disrupted.
Inhibition of PDGF-induced MAPK1/MAPK3 activation by DPI and induction of MAPK1/MAPK3 activation by exogenous hydrogen peroxide suggest that ROS are necessary and sufficient to trigger the MAPK1/MAPK3 signaling pathway associated with PDGF. The fact that the responsiveness of LSMCs to EGF with regard to MAPK1/MAPK3 activation seemed unaffected by the presence of DPI may suggest another level of specificity to the role of ROS in regulating the PDGF signaling pathway. Although our study provides new information regarding the role of ROS in leiomyoma SMCs, MAPK1/ MAPK3 activation in response to hydrogen peroxide has been observed previously in vascular smooth muscle cells, in agreement with our results [47] . Several studies have reported activation of a variety of specific downstream targets including ROS-dependent p38MAPK activation but not MAPK1/ MAPK3 [19] , activation of both MAPK1/MAPK3 and MAPK14 [48] , as well as activation of only MAPK8 [25] . Some of the studies utilized NADPH oxidase inhibitors or ROS scavengers to confirm participation of ROS in these signaling pathways, whereas others tested the effects of exogenous hydrogen peroxide at concentrations ranging from 5-to 100-fold higher than those used in our study. The use of different hydrogen peroxide concentrations may explain the discrepancies between our results and those of others. ROS are involved in the activation of several signaling events including regulation of EGF and PDGF receptor activation or transactivation through induction of CSK activity [23, 49] , VEGFdependent HIF1 activation [50] , IL1-dependent regulation of MP3K14 [51] , TGFB1-dependent activation of EGR1 gene expression [52] , and ultimately, the regulation of protein tyrosine phosphatase activity. Hydrogen peroxide cannot directly phosphorylate proteins, but it can specifically oxidize certain cysteine residues within protein tyrosine phosphatases, which then become unavailable to interact with phosphate substrates, rendering the enzyme inactive [39, 40] . Redox regulation of protein tyrosine phosphatases such as PTEN, PTPN1, ACP1, and CDC25C, has been reported [53] [54] [55] [56] . Furthermore, the importance of PTPs in regulating the level of activation of growth factor receptors and the role of reductases in counteracting the effects of oxidants on PTPs during cell signaling have also been confirmed [57] [58] [59] . Whether NADPH oxidase-derived ROS affect proliferation and activation of MAPK1/MAPK3 pathways in LSMCs by regulating protein tyrosine phosphatase activity remains to be tested.
The involvement of ROS generated through the NADPH oxidase complex in the development of chronic diseases including fibrotic conditions such as pulmonary, hepatic, and pancreatic fibrosis has been proposed recently by other investigators [60] . Many of these disorders are associated with overproduction of ROS and are linked to higher expression of the NADPH oxidase subunits [60] . The increased production of ROS may occur as part of an inflammatory response and may contribute to the abnormal cell proliferation that is observed in conditions such as atherosclerosis or diabetic vascular disease. Drugs that can target the NADPH oxidase complex such as specific inhibitors of the NOX/DUOX family members represent potential therapeutic approaches for treatment of these chronic diseases [61] . Uterine leiomyomas are also an example of a chronic fibrotic disease, and thus the characterization and understanding of the NADPH oxidase complex in LSMCs may be important for future directions in treatment of these tumors.
In summary, the findings of our research suggest that reactive oxygen species are an important component of the EGF and PDGF signaling pathways involved in LSMC proliferation. Specifically regarding the PDGF signaling pathway, our data suggest that the activation of MAPK1/ MAPK3 is an important step following PDGF-induced ROS production, which may be necessary for ROS-induced LSMC proliferation. This mechanism is likely occurring through the stimulation of NADPH oxidase and the subsequent generation of intracellular ROS. Our findings provide the first evidence of 1) ROS as a second messenger in LSMCs proliferation and 2) a nonphagocytic NADPH oxidase complex in leiomyoma smooth muscle cells. This research presents a novel target for the development of preventive strategies or therapeutic approaches to treat uterine leiomyomas through the targeting of intracellular ROS and, specifically, NADPH oxidase. Although no differences were observed between normal myometrial cells and leiomyoma cells in regard to the influence of NADPH oxidase-derived ROS on the signaling pathways examined, the presence of the complex in myometrial and leiomyoma cells provides the basis to investigate other pathways.
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